Univercell Biosolutions Overview

  • Founded
  • 2010
Founded
  • Status
  • Out of Business
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Out of Business

Univercell Biosolutions General Information

Description

Developer of human stem cells, cellular reprogramming and differentiation technologies designed to accelerate drug discovery and development with more informative and innovative human cell models. The company's technologies offer collaborations with relevant and robust human-induced pluripotent stem cells tailored to fit with most differentiation protocols, enabling customers and medical care professionals to get access to well-characterized and standardized human-induced pluripotent stem cells (hiPSc).

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 1 Place Pierre Potier
  • Canceropole, Entree B
  • 31106 Toulouse Cedex
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Univercell Biosolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 14-Jul-2021 Completed Out of Business
3. Later Stage VC Completed Generating Revenue
2. Grant 31-Jan-2017 $53.2K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Univercell Biosolutions’s complete valuation and funding history, request access »

Univercell Biosolutions Patents

Univercell Biosolutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2594635-A1 Method for generating primate cardiovascular progenitor cells for clinical and drug cells testing use from primate embryonic stem cells or embryonic-like state cells, and their applications Withdrawn 18-Nov-2011 0000000000 0

Univercell Biosolutions Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Univercell Biosolutions Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 01-Dec-2015 000000000000000000 Biotechnology
To view Univercell Biosolutions’s complete acquisitions history, request access »